Identification and Structural Characterization of an Unknown Trace Degradation Impurity in Cabazitaxel Injection by LC-DAD-SPE-NMR/MS

In this work, the hyphenated liquid chromatography-diode array detector-solid phase extraction-nuclear magnetic resonance/mass spectrometry (LC-DAD-SPE-NMR/MS) technique is employed to characterize a novel degradation impurity with an approximate content of 0.3%~0.4% in cabazitaxel injection. In LC...

Full description

Bibliographic Details
Published in:	Chinese Journal of Magnetic Resonance
Main Authors:	LIU Hongbing, LIU Huili, LUO Liting, SUN Lijuan, CHEN Lei
Format:	Article
Language:	Chinese
Published:	Science Press 2025-03-01
Subjects:	cabazitaxel degradation impurity lc-dad-spe-nmr/ms structure elucidation analytical method
Online Access:	http://121.43.60.238/bpxzz/article/2025/1000-4556/1000-4556-42-1-34.shtml

Similar Items

Combining HPLC-DAD-QTOF-MS and HPLC-SPE-NMR to Monitor In Vitro Vitetrifolin D Phase I and II Metabolism
by: Sonja Sturm, et al.
Published: (2021-08-01)

NMR-Based Chromatography Readouts: Indispensable Tools to “Translate” Analytical Features into Molecular Structures
by: Christoph Seger, et al.
Published: (2022-11-01)

SPE-HPLC-DAD Dosage of Seven Neonicotinoids in Green Coffee
by: Serenella Seccia, et al.
Published: (2025-04-01)

A Validated Ultrasound-Assisted Extraction Coupled with SPE-HPLC-DAD for the Determination of Flavonoids in By-Products of Plant Origin: An Application Study for the Valorization of the Walnut Septum Membrane
by: Natasa P. Kalogiouri, et al.
Published: (2021-10-01)

Rapid Structure Determination of Bioactive 4″-Tetrahydrofurfuryl Macrozone Reaction Mixture Components by LC-SPE/Cryo NMR and MS
by: Iva Habinovec, et al.
Published: (2021-10-01)

ESTIMATION OF TOXIC EFFECTS OF MEDICINAL PREPARATION OF CABAZITAXEL
by: O. I. Avdeeva, et al.
Published: (2019-01-01)

Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
by: Anna Petruczynik, et al.
Published: (2020-05-01)

Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted solutions in three infusion bags
by: D’Huart Elise, et al.
Published: (2023-07-01)

Screening of Novel Antimicrobial Diastereomers of Azithromycin–Thiosemicarbazone Conjugates: A Combined LC-SPE/Cryo NMR, MS/MS and Molecular Modeling Approach
by: Iva Habinovec, et al.
Published: (2022-12-01)

Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells
by: Charles eKunos, et al.
Published: (2013-09-01)

Topical Drug Delivery of Concentrated Cabazitaxel in an α‐Tocopherol and DMSO Solution
by: Boyang Sun, et al.
Published: (2023-10-01)

Recent Developments Toward Integrated Metabolomics Technologies (UHPLC-MS-SPE-NMR and MicroED) for Higher-Throughput Confident Metabolite Identifications
by: Rajarshi Ghosh, et al.
Published: (2021-09-01)

Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy
by: Yuting Liu, et al.
Published: (2023-01-01)

Qualitative and Quantitative Evaluation of Rosavin, Salidroside, and p-Tyrosol in Artic Root Products via TLC-Screening, HPLC-DAD, and NMR Spectroscopy
by: Hanna Nikolaichuk, et al.
Published: (2022-11-01)

HILIC-DAD Method for Simultaneous Determination of Acid and Basic Drugs: Application to the Quantitation of Ibuprofen, Atenolol, and Salbutamol in Urine After Solid-Phase Extraction
by: Noelia Rosales-Conrado, et al.
Published: (2025-01-01)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
by: Nagavendra Kommineni, et al.
Published: (2019-03-01)

Cytotoxic Effect of 6-Ethyl-Chenodeoxycholic Acid and Cabazitaxel on PC-3 Cells
by: M. H. Zalzala, et al.
Published: (2023-02-01)

Cabazitaxel in the treatment of castration-resistant cancer: hitting the balance of efficacy and safety
by: M. I. Volkova, et al.
Published: (2019-06-01)

Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
by: Mário Sousa-Pimenta, et al.
Published: (2023-05-01)

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
by: Naoki Terada, et al.
Published: (2019-02-01)

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
by: Hakan Taban, et al.
Published: (2025-06-01)

Encyklika Spe salvi: śladami Augustyna
by: Waldemar Jan Turek
Published: (2008-03-01)

Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
by: Wen Zhang, et al.
Published: (2021-11-01)

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
by: Vanita Noronha, et al.
Published: (2016-08-01)

Synthesis and Physicochemical Characterization of the Impurities of Pemetrexed Disodium, an Anticancer Drug
by: Olga Michalak, et al.
Published: (2015-05-01)

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study
by: Takashi Matsumoto, et al.
Published: (2021-06-01)

Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014–2024
by: Ahmed H. Zedan, et al.
Published: (2025-04-01)

Simultaneous Determination of Isothiazolinones and Parabens in Cosmetic Products Using Solid-Phase Extraction and Ultra-High Performance Liquid Chromatography/Diode Array Detector
by: Hazim Mohammed Ali, et al.
Published: (2020-11-01)

Development of a SPE-LC-MS Method for the Quantitation of Palbociclib and Abemaciclib in Human Plasma
by: Daniela Maria Calucică, et al.
Published: (2022-12-01)

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
by: Valsalakumari R, et al.
Published: (2024-03-01)

Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin
by: Shigeaki Katsumi, et al.
Published: (2023-07-01)

NMR Analysis of 2-(2, 3-dihydro-1H-inden-1-yl)-1H-indene
by: PETER SPITELLER, et al.
Published: (2001-12-01)

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
by: Nicholas D. James, et al.
Published: (2022-11-01)

The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells
by: Işıl Ezgi Eryılmaz, et al.
Published: (2021-12-01)

Discovery and Structural Characterization of Impurities in the Synthesis of Darolutamide Intermediate
by: MA Huifang, et al.
Published: (2024-03-01)

Cetuximab functionalized chitosan/hyaluronic acid-based nanoparticles loaded with cabazitaxel enhances anti-tumor efficacy in DMBA-induced breast cancer model in rats through spatial targeting
by: Abhishek Jha, et al.
Published: (2024-12-01)

Characterization of Antileishmanial Compounds from Lawsonia inermis L. Leaves Using Semi-High Resolution Antileishmanial Profiling Combined with HPLC-HRMS-SPE-NMR
by: Kashif Iqbal, et al.
Published: (2017-05-01)

Structural Elucidation and NMR Spectral Assignments of Two C19-Diterpenoid Alkaloids
by: YIN Tian-peng, et al.
Published: (2018-03-01)

Report of 4th International SPE Balkan Ski Conference
by: Kaja Teraž, et al.
Published: (2022-12-01)

Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel
by: Haopeng Li, et al.
Published: (2024-05-01)